H. Lundbeck A/S (HLUBF)
OTCMKTS · Delayed Price · Currency is USD
5.35
0.00 (0.00%)
Dec 15, 2025, 4:00 PM EST
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $6.49 billion as of December 16, 2025. Its market cap has increased by 8.67% in one year.
Market Cap
6.49B
Enterprise Value
7.90B
Revenue
3.78B
Ranking
n/a
PE Ratio
10.85
Stock Price
$5.35
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 6.49B, an increase of 43.07%. That is a compound annual growth rate of 10.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 6.49B | 18.35% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
| Jun 10, 2022 | 4.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |